Physician profile
Irwin Ingwer
NPI 1356386239
$916.70
in general payments reported to CMS, 2019-2025
18 companies · $185 in 2025
The $185 reported for 2025 was less than what a typical Infectious Disease provider received nationally (typical 2025 total: $187).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.30 · 2020: $110 · 2021: $192 · 2022: $144 · 2023: $61.13 · 2024: $200 · 2025: $185.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $447.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $446.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $179.57 | 2020-2022 | |
| Novo Nordisk INC | $110.46 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Abbvie INC. | $86.57 | 2024-2025 | |
| Lilly USA, LLC | $67.59 | 2024-2025 | Zepbound, Jardiance, Mounjaro |
| Astrazeneca Pharmaceuticals Lp | $63.40 | 2021-2025 | Farxiga |
| Novartis Pharmaceuticals Corporation | $58.07 | 2022-2024 | |
| Amgen INC. | $47.45 | 2021 | |
| Edwards Lifesciences Corporation | $39.99 | 2023 | Sapien 3 Ultra Resilia |
| Medicomp INC | $39.08 | 2025 | Telepatch Cardiac Monitor |
| Tactile Systems Technology INC | $35.57 | 2024-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Kiniksa Pharmaceuticals, Ltd. | $34.55 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.84 | 2022 | |
| Amarin Pharma, INC. | $26.22 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $24.76 | 2020-2021 | |
| Abbott Laboratories | $23.00 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $20.63 | 2020 | |
| Pfizer INC. | $18.25 | 2021 | |
| Genentech USA, INC. | $14.70 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Irwin Ingwer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.